Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry

Reem Z. Sharaiha, Amrita Sethi, Kristen R. Weaver, Tamas A. Gonda, Raj J. Shah, Norio Fukami, Prashant Kedia, Nikhil A. Kumta, Carlos M.Rondon Clavo, Michael D. Saunders, Jorge Cerecedo-Rodriguez, Paola Figueroa Barojas, Jessica L. Widmer, Monica Gaidhane, William R. Brugge, Michel Kahaleh

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Radiofrequency ablation of malignant biliary strictures has been offered for the last 3 years, but only limited data have been published. Aim: To assess the safety, efficacy, and survival outcomes of patients receiving endoscopic radiofrequency ablation. Methods: Between April 2010 and December 2013, 69 patients with unresectable neoplastic lesions and malignant biliary obstruction underwent 98 radiofrequency ablation sessions with stenting. Results: A total of 69 patients (22 male, aged 66.1 ± 13.3) were included in the registry. The etiology of malignant biliary stricture included unresectable cholangiocarcinoma (n = 45), pancreatic cancer (n = 19), gallbladder cancer (n = 2), gastric cancer (n = 1), and liver metastasis from colon cancer (n = 3). Seventy-eight percentage of patients had prior chemotherapy. All strictures were stented post-radiofrequency ablation with either plastic stents or metal stents. The mean stricture length treated was 14.3 mm. There was a statistically significant improvement in stricture diameter post-ablation (p < 0.0001). The likelihood of stricture improvement was significantly greater in pancreatic cancer-associated strictures [RR 1.8 (95 % 1.03–5.38)]. Seven patients (10 %) had adverse events, not linked directly to radiofrequency ablation. Median survival was 11.46 months (6.2–25 months). Conclusion: Radiofrequency ablation is effective and safe in malignant biliary obstruction and seems to be associated with improved survival.

Original languageEnglish (US)
Pages (from-to)2164-2169
Number of pages6
JournalDigestive Diseases and Sciences
Volume60
Issue number7
DOIs
StatePublished - Jul 13 2015
Externally publishedYes

Fingerprint

Registries
Pathologic Constriction
Pancreatic Neoplasms
Stents
Survival
Gallbladder Neoplasms
Cholangiocarcinoma
Colonic Neoplasms
Plastics
Stomach Neoplasms
Metals
Neoplasm Metastasis
Safety
Drug Therapy
Liver

Keywords

  • Biliary obstruction
  • Cholangiocarcinoma
  • Pancreatic cancer
  • Radiofrequency ablation
  • Stent patency
  • Survival

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Impact of Radiofrequency Ablation on Malignant Biliary Strictures : Results of a Collaborative Registry. / Sharaiha, Reem Z.; Sethi, Amrita; Weaver, Kristen R.; Gonda, Tamas A.; Shah, Raj J.; Fukami, Norio; Kedia, Prashant; Kumta, Nikhil A.; Clavo, Carlos M.Rondon; Saunders, Michael D.; Cerecedo-Rodriguez, Jorge; Barojas, Paola Figueroa; Widmer, Jessica L.; Gaidhane, Monica; Brugge, William R.; Kahaleh, Michel.

In: Digestive Diseases and Sciences, Vol. 60, No. 7, 13.07.2015, p. 2164-2169.

Research output: Contribution to journalArticle

Sharaiha, RZ, Sethi, A, Weaver, KR, Gonda, TA, Shah, RJ, Fukami, N, Kedia, P, Kumta, NA, Clavo, CMR, Saunders, MD, Cerecedo-Rodriguez, J, Barojas, PF, Widmer, JL, Gaidhane, M, Brugge, WR & Kahaleh, M 2015, 'Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry', Digestive Diseases and Sciences, vol. 60, no. 7, pp. 2164-2169. https://doi.org/10.1007/s10620-015-3558-3
Sharaiha, Reem Z. ; Sethi, Amrita ; Weaver, Kristen R. ; Gonda, Tamas A. ; Shah, Raj J. ; Fukami, Norio ; Kedia, Prashant ; Kumta, Nikhil A. ; Clavo, Carlos M.Rondon ; Saunders, Michael D. ; Cerecedo-Rodriguez, Jorge ; Barojas, Paola Figueroa ; Widmer, Jessica L. ; Gaidhane, Monica ; Brugge, William R. ; Kahaleh, Michel. / Impact of Radiofrequency Ablation on Malignant Biliary Strictures : Results of a Collaborative Registry. In: Digestive Diseases and Sciences. 2015 ; Vol. 60, No. 7. pp. 2164-2169.
@article{dcddb8db39ff4599b43c4a4790721573,
title = "Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry",
abstract = "Background: Radiofrequency ablation of malignant biliary strictures has been offered for the last 3 years, but only limited data have been published. Aim: To assess the safety, efficacy, and survival outcomes of patients receiving endoscopic radiofrequency ablation. Methods: Between April 2010 and December 2013, 69 patients with unresectable neoplastic lesions and malignant biliary obstruction underwent 98 radiofrequency ablation sessions with stenting. Results: A total of 69 patients (22 male, aged 66.1 ± 13.3) were included in the registry. The etiology of malignant biliary stricture included unresectable cholangiocarcinoma (n = 45), pancreatic cancer (n = 19), gallbladder cancer (n = 2), gastric cancer (n = 1), and liver metastasis from colon cancer (n = 3). Seventy-eight percentage of patients had prior chemotherapy. All strictures were stented post-radiofrequency ablation with either plastic stents or metal stents. The mean stricture length treated was 14.3 mm. There was a statistically significant improvement in stricture diameter post-ablation (p < 0.0001). The likelihood of stricture improvement was significantly greater in pancreatic cancer-associated strictures [RR 1.8 (95 {\%} 1.03–5.38)]. Seven patients (10 {\%}) had adverse events, not linked directly to radiofrequency ablation. Median survival was 11.46 months (6.2–25 months). Conclusion: Radiofrequency ablation is effective and safe in malignant biliary obstruction and seems to be associated with improved survival.",
keywords = "Biliary obstruction, Cholangiocarcinoma, Pancreatic cancer, Radiofrequency ablation, Stent patency, Survival",
author = "Sharaiha, {Reem Z.} and Amrita Sethi and Weaver, {Kristen R.} and Gonda, {Tamas A.} and Shah, {Raj J.} and Norio Fukami and Prashant Kedia and Kumta, {Nikhil A.} and Clavo, {Carlos M.Rondon} and Saunders, {Michael D.} and Jorge Cerecedo-Rodriguez and Barojas, {Paola Figueroa} and Widmer, {Jessica L.} and Monica Gaidhane and Brugge, {William R.} and Michel Kahaleh",
year = "2015",
month = "7",
day = "13",
doi = "10.1007/s10620-015-3558-3",
language = "English (US)",
volume = "60",
pages = "2164--2169",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Impact of Radiofrequency Ablation on Malignant Biliary Strictures

T2 - Results of a Collaborative Registry

AU - Sharaiha, Reem Z.

AU - Sethi, Amrita

AU - Weaver, Kristen R.

AU - Gonda, Tamas A.

AU - Shah, Raj J.

AU - Fukami, Norio

AU - Kedia, Prashant

AU - Kumta, Nikhil A.

AU - Clavo, Carlos M.Rondon

AU - Saunders, Michael D.

AU - Cerecedo-Rodriguez, Jorge

AU - Barojas, Paola Figueroa

AU - Widmer, Jessica L.

AU - Gaidhane, Monica

AU - Brugge, William R.

AU - Kahaleh, Michel

PY - 2015/7/13

Y1 - 2015/7/13

N2 - Background: Radiofrequency ablation of malignant biliary strictures has been offered for the last 3 years, but only limited data have been published. Aim: To assess the safety, efficacy, and survival outcomes of patients receiving endoscopic radiofrequency ablation. Methods: Between April 2010 and December 2013, 69 patients with unresectable neoplastic lesions and malignant biliary obstruction underwent 98 radiofrequency ablation sessions with stenting. Results: A total of 69 patients (22 male, aged 66.1 ± 13.3) were included in the registry. The etiology of malignant biliary stricture included unresectable cholangiocarcinoma (n = 45), pancreatic cancer (n = 19), gallbladder cancer (n = 2), gastric cancer (n = 1), and liver metastasis from colon cancer (n = 3). Seventy-eight percentage of patients had prior chemotherapy. All strictures were stented post-radiofrequency ablation with either plastic stents or metal stents. The mean stricture length treated was 14.3 mm. There was a statistically significant improvement in stricture diameter post-ablation (p < 0.0001). The likelihood of stricture improvement was significantly greater in pancreatic cancer-associated strictures [RR 1.8 (95 % 1.03–5.38)]. Seven patients (10 %) had adverse events, not linked directly to radiofrequency ablation. Median survival was 11.46 months (6.2–25 months). Conclusion: Radiofrequency ablation is effective and safe in malignant biliary obstruction and seems to be associated with improved survival.

AB - Background: Radiofrequency ablation of malignant biliary strictures has been offered for the last 3 years, but only limited data have been published. Aim: To assess the safety, efficacy, and survival outcomes of patients receiving endoscopic radiofrequency ablation. Methods: Between April 2010 and December 2013, 69 patients with unresectable neoplastic lesions and malignant biliary obstruction underwent 98 radiofrequency ablation sessions with stenting. Results: A total of 69 patients (22 male, aged 66.1 ± 13.3) were included in the registry. The etiology of malignant biliary stricture included unresectable cholangiocarcinoma (n = 45), pancreatic cancer (n = 19), gallbladder cancer (n = 2), gastric cancer (n = 1), and liver metastasis from colon cancer (n = 3). Seventy-eight percentage of patients had prior chemotherapy. All strictures were stented post-radiofrequency ablation with either plastic stents or metal stents. The mean stricture length treated was 14.3 mm. There was a statistically significant improvement in stricture diameter post-ablation (p < 0.0001). The likelihood of stricture improvement was significantly greater in pancreatic cancer-associated strictures [RR 1.8 (95 % 1.03–5.38)]. Seven patients (10 %) had adverse events, not linked directly to radiofrequency ablation. Median survival was 11.46 months (6.2–25 months). Conclusion: Radiofrequency ablation is effective and safe in malignant biliary obstruction and seems to be associated with improved survival.

KW - Biliary obstruction

KW - Cholangiocarcinoma

KW - Pancreatic cancer

KW - Radiofrequency ablation

KW - Stent patency

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84930819085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930819085&partnerID=8YFLogxK

U2 - 10.1007/s10620-015-3558-3

DO - 10.1007/s10620-015-3558-3

M3 - Article

C2 - 25701319

AN - SCOPUS:84930819085

VL - 60

SP - 2164

EP - 2169

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 7

ER -